scholarly article | Q13442814 |
P50 | author | Johannes Haybaeck | Q56955634 |
Tobias Kiesslich | Q73178545 | ||
P2093 | author name string | Marc D Bullock | |
Martin Pichler | |||
Armin Gerger | |||
Michael Stotz | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 5737-5744 | |
P577 | publication date | 2015-11-01 | |
P1433 | published in | Anticancer Research | Q326290 |
P1476 | title | Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future | |
P478 | volume | 35 |
Q47159418 | 20(S)-Protopanaxadiol enhances angiogenesis via HIF-1α-mediated VEGF secretion by activating p70S6 kinase and benefits wound healing in genetically diabetic mice |
Q26740313 | Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis |
Q47193804 | Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and in vitro investigation |
Q41471395 | Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development |
Q36879787 | Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model. |
Q42679004 | Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance |
Q59135320 | Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma |
Q61813759 | Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients |
Q52694975 | Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma. |
Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
Q92876631 | Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies |
Q41632307 | Inhibition of mTORC1 signaling sensitizes hepatocellular carcinoma cells to glycolytic stress |
Q47156516 | Jujube leaf green tea extracts inhibits hepatocellular carcinoma cells by activating AMPK. |
Q92134426 | KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma |
Q58806320 | LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21 |
Q91828636 | LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells |
Q93193698 | Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma |
Q55646454 | Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept. |
Q37360440 | Multifunctional SPIO/DOX-loaded A54 Homing Peptide Functionalized Dextran-g-PLGA Micelles for Tumor Therapy and MR Imaging |
Q58758006 | Role of canonical Hedgehog signaling pathway in liver |
Q54251317 | SIRT6 Depletion Sensitizes Human Hepatoma Cells to Chemotherapeutics by Downregulating MDR1 Expression. |
Q47094928 | SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types. |
Q57301434 | Systemic treatments for hepatocellular carcinoma: challenges and future perspectives |
Q33592056 | The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data |
Search more.